Sfoglia per Autore
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients.
2013-01-01 L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi
Metabolic alterations of lipid kinetics in NAFLD patients and their contribution to liver damage.
2013-01-01 C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; S. Carenzi; F. Saba; E. Buzzigoli; M. Gaggini; G.P. Caviglia; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi.
Lipid modifiers and NASH: statins, ezetimibe, fibrates and other agents
2013-01-01 Musso G; Molinaro F; Paschetta E; Gambino R; Cassader M
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
2013-01-01 Musso G; Gambino R; Cassader M.
Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism
2013-01-01 Musso G; Bo S; Cassader M; De Michieli F; Gambino R
SREBF-1C polymorphism affects postprandial lipid metabolism in NAFLD subjects.
2013-01-01 R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; V. Nuvoli; F. Saba; M. Cassader
PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C
2013-01-01 Rosso C; Petta S; Abate ML; Vanni E; Mezzabotta L; Grimaudo S; Caviglia GP; Gambino R; Cassader M; Rizzetto M; Smedile A; Bugianesi E
VARIATIONS OF SERUM LEVELS OF ADIPONECTIN AND RESISTIN IN CHRONIC VIRAL HEPATITIS
2013-01-01 Durazzo M; Belci P; Niro G; Collo A; Grisoglio E; Ambrogio V; Spandre M; Fontana R; Gambino R; Cassader M; Bo S
Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis.
2013-01-01 Musso G; Cassader M; Olivetti C; Rosina F; Carbone G; Gambino R
Metabolic alterations of lipid kinetics in NAFLD patients and their contribution to liver damage.
2013-01-01 C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; S. Carenzi; F. Saba; E. Buzzigoli; M. Gaggini; G.P. Caviglia; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi
Alteration in lipid metabolism after an oral fat load in subjects with NAFLD.
2013-01-01 Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E
Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients.
2013-01-01 L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial
2013-01-01 Bo S; Ciccone G; Castiglione A; Gambino R; DE MICHIELI F; Villois P; Durazzo M; Cavallo-Perin P; Cassader M
Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism.
2013-01-01 Musso G; Cassader M; Bo S; De Michieli F; Gambino R.
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver.
2013-01-01 Musso G;Paschetta E;Gambino R;Cassader M;Molinaro F
La condizione di normopeso, sovrappeso e obeso.
2012-01-01 P. Villois; G. Musso; R. Gambino; M. Durazzo; M. Cassader; P. Cavallo-Perin; S. Bo.
IL28B gene variants and metabolic profile in patients with genotype 1 chronic hepatitis C
2012-01-01 Rosso, Chiara; Abate, Maria Lorena; Leung, R.; Booth, D.; Mezzabotta, L.; Carenzi, S.; Caviglia, GIAN PAOLO; Salamone, F.; Gambino, Roberto; Cassader, Maurizio; Rizzetto, Mario; Smedile, Antonina; George, J.; Bugianesi, Elisabetta
INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM.
2012-01-01 R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; M. Potenza; F. Saba; M. Cassader.
A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials.
2012-01-01 Musso G; Gambino R; Cassader M; Pagano G
Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort
2012-01-01 Bo S; Musso G; Gambino R; Villois P; Gentile L; Durazzo M; Cavallo Perin P; Cassader M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients. | 2013 | L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi | |
| Metabolic alterations of lipid kinetics in NAFLD patients and their contribution to liver damage. | 2013 | C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; S. Carenzi; F. Saba; E. Buzzigoli; M. Gaggini; G.P. Caviglia; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi. | |
| Lipid modifiers and NASH: statins, ezetimibe, fibrates and other agents | 2013 | Musso G; Molinaro F; Paschetta E; Gambino R; Cassader M | |
| Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. | 2013 | Musso G; Gambino R; Cassader M. | |
| Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism | 2013 | Musso G; Bo S; Cassader M; De Michieli F; Gambino R | |
| SREBF-1C polymorphism affects postprandial lipid metabolism in NAFLD subjects. | 2013 | R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; V. Nuvoli; F. Saba; M. Cassader | |
| PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C | 2013 | Rosso C; Petta S; Abate ML; Vanni E; Mezzabotta L; Grimaudo S; Caviglia GP; Gambino R; Cassader M; Rizzetto M; Smedile A; Bugianesi E | |
| VARIATIONS OF SERUM LEVELS OF ADIPONECTIN AND RESISTIN IN CHRONIC VIRAL HEPATITIS | 2013 | Durazzo M; Belci P; Niro G; Collo A; Grisoglio E; Ambrogio V; Spandre M; Fontana R; Gambino R; Cassader M; Bo S | |
| Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. | 2013 | Musso G; Cassader M; Olivetti C; Rosina F; Carbone G; Gambino R | |
| Metabolic alterations of lipid kinetics in NAFLD patients and their contribution to liver damage. | 2013 | C. Rosso; E. Vanni; L. Mezzabotta; R. Gambino; S. Carenzi; F. Saba; E. Buzzigoli; M. Gaggini; G.P. Caviglia; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi | |
| Alteration in lipid metabolism after an oral fat load in subjects with NAFLD. | 2013 | Gastaldelli A.; Gaggini M.; Mezzabotta L.; Rosso C.; Carli F.; Ciociaro D.; Gambino R.; Carenzi S.; Saba F.; Cassader M.; Bugianesi E | |
| Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients. | 2013 | L. Mezzabotta; E. Vanni; C. Rosso; S. Carenzi; R. Gambino; M. Gaggini; D. Lucarelli; R. Faletti; M. Cassader; A. Smedile; M. Rizzetto; A. Gastaldelli; E. Bugianesi | |
| Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial | 2013 | Bo S; Ciccone G; Castiglione A; Gambino R; DE MICHIELI F; Villois P; Durazzo M; Cavallo-Perin P; Cassader M | |
| Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism. | 2013 | Musso G; Cassader M; Bo S; De Michieli F; Gambino R. | |
| Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. | 2013 | Musso G;Paschetta E;Gambino R;Cassader M;Molinaro F | |
| La condizione di normopeso, sovrappeso e obeso. | 2012 | P. Villois; G. Musso; R. Gambino; M. Durazzo; M. Cassader; P. Cavallo-Perin; S. Bo. | |
| IL28B gene variants and metabolic profile in patients with genotype 1 chronic hepatitis C | 2012 | Rosso, Chiara; Abate, Maria Lorena; Leung, R.; Booth, D.; Mezzabotta, L.; Carenzi, S.; Caviglia, GIAN PAOLO; Salamone, F.; Gambino, Roberto; Cassader, Maurizio; Rizzetto, Mario; Smedile, Antonina; George, J.; Bugianesi, Elisabetta | |
| INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM. | 2012 | R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; M. Potenza; F. Saba; M. Cassader. | |
| A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials. | 2012 | Musso G; Gambino R; Cassader M; Pagano G | |
| Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort | 2012 | Bo S; Musso G; Gambino R; Villois P; Gentile L; Durazzo M; Cavallo Perin P; Cassader M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile